Knobbe Martens Earns Multiple Shortlistings at 2026 Financial Times Innovative Lawyers Awards
IRVINE, Calif., October 13, 2026 – Knobbe Martens has been shortlisted as among the country’s most innovative law firms at the 2026 Financial Times Innovative Lawyers North America Awards. The...
AI-Enabled Medical Devices Require an Integrated FDA and IP Strategy
Key Takeaway: Medical device companies should prepare a cohesive patent and premarket submission strategy by considering FDA recommendations when developing AI-enabled features and coordinating statements made to the Patent Office...
FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors
Key Takeaways: The Expedited Investigational New Drug (IND) Pilot Program is intended to evaluate whether leveraging qualified research institutions (QRIs) and a rolling review process can improve the efficiency of...
Knobbe Martens Named a California Powerhouse by Law360
Publication highlights firm’s across-the-board strength in intellectual property law IRVINE, Calif., September 24, 2026 – Knobbe Martens is proud to announce that it has been named among Law360’s 2026 California...
Knobbe Martens Takes Home Multiple Honors at 2026 OCCDL Awards Gala
Firm receives Legacy Award; Geetha Durairaj and Nefi Oliva named among Top Lawyers IRVINE, Calif., September 23, 2026 – Knobbe Martens is pleased to share that the firm and two...
Knobbe Martens Partners Named Among “Leading Litigators in America” by Lawdragon
IRVINE, Calif., September 23, 2026 – Knobbe Martens is proud to share that 17 of the firm’s partners were recognized in the 2027 edition of Lawdragon 500 Leading Litigators in...
Permission Granted: D.C. Circuit Preserves Medical Device Repair Access
Key Takeaway(s): Medical device companies should treat copyright as just one part of a layered protection strategy. The DMCA repair exemption preserves meaningful access for qualifying third-party diagnosis, maintenance, and...
Knobbe Martens, Partner Christy Lea Honored at 2026 LMG Life Sciences Awards
Ms. Lea honored as “Patent Litigator of the Year”, firm takes home Impact Case honor IRVINE, Calif., September 11, 2026 – Knobbe Martens is pleased to share that the firm...
AI-Powered Skin Cancer Detection Device Developer Announces Commercialization Partnerships
On September 1, 2026, medical device company DermaSensor Inc. announced four new industry partnerships. DermaSensor is focused on early detection of skin cancer. DermaSensor’s website states: “The DermaSensor device is the...
Ben Shiroma Featured in Am Law’s “How I Made Partner” Series
Knobbe Martens partner Ben Shiroma shared reflections on his path to becoming an IP litigation partner at the firm and his approach to long-term career growth in Am Law’s “How...
FDA Issues Discussion Paper Regarding Regulation of Generative AI-Enabled Medical Devices
Key Takeaway: The FDA’s recent discussion paper seeking feedback regarding the regulation of generative AI-enabled medical devices suggests that the FDA has focused on evaluating, monitoring, and regulating such devices...
Dozens of Knobbe Martens Lawyers Recognized in 2027 Best Lawyers in America Guides
IRVINE, Calif., August 20, 2026 – Leading intellectual property law firm Knobbe Martens is pleased to share that more than 40 firm lawyers have been featured in the 2027 editions...
Knobbe Martens Partners Named Among Global IP Leaders in IAM Strategy 300 Guide
IRVINE, Calif., August 14, 2026 – Knobbe Martens is proud to share that eight of the firm’s partners were recognized in the 2026 edition of IAM Strategy 300: The World’s...
Knobbe Martens Names Harnik Shukla and Bryan McWhorter Co-Chairs of Artificial Intelligence Practice
New co-chairs will guide strategy and focus of firm’s longstanding work at the intersection of AI and intellectual property IRVINE, Calif. and SEATTLE, August 4, 2026 – Leading intellectual property law firm Knobbe Martens is...
FDA to Hold Public Meeting on Proposed Medical Device Review Recommendations
Key Takeaway: The FDA announced a public meeting and request for comments on proposed Medical Device User Fee Amendments (MDUFA )recommendations for fiscal years 2028-2032, which would govern medical device...
Knobbe Martens Shortlisted in Eight Categories for 2026 LMG Life Sciences Awards, Including Firm of the Year
IRVINE, Calif., July 22, 2026 – Leading intellectual property law firm Knobbe Martens is proud to share that the firm and several of its partners are shortlisted in eight categories...
Brian Horne Named Among Los Angeles Business Journal’s 2026 “Leaders of Influence: Litigators & Trial Attorneys”
LOS ANGELES, July 16, 2026 – Knobbe Martens is pleased to share that litigation partner Brian Horne was recognized in the 2026 edition of Los Angeles Business Journal’s “Leaders of...
Profiles in Leadership Journal Recognizes Four Knobbe Martens Partners in 2026 Mid-Year Leadership Awards
IRVINE, Calif., July 14, 2026 – Leading intellectual property law firm Knobbe Martens is pleased to share that four of the firm’s partners—Jessica Achtsam, Charlene Azema, Irfan Lateef, and Christy...
Amendments to Mexico’s Federal Law for Protection of Industrial Property Inform More Flexible International IP Strategy for Biotech Companies
Key Takeaway: Amendments to Mexico’s Federal Law for Protection of Industrial Property align more with U.S. Patent and Trademark Office standards for restoring priority and application revival, increasing international patent...
FDA to Drop 510(k) Requirements for Certain Low-Risk Devices, Lowering Barriers to Entry
On June 5, 2026, the U.S. Food and Drug Administration (FDA) issued updated guidance stating its intent to exempt certain unclassified medical devices from premarket 510(k) requirements, and that the FDA believes the identified device...
Knobbe Martens, Dozens of Partners Receive Top Rankings in IP Law in Legal 500 USA Guide
IRVINE, Calif., June 11, 2026 – Knobbe Martens, a leading intellectual property law firm, is proud to share that the firm and three dozen lawyers received national and regional recognition...
